is retatrutide approved in europe ESC 2024: Retatrutide improves lipid
Description
New data suggests GLP-1 medications may also change how people spend their money
An actual timeline
W., Gabe, M
Glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus
Germany is expected to register the highest CAGR in the Europe Glucagon-Like Peptide-1 Agonists Market over the forecast period Germany is expected to register the highest CAGR of about 7.8% in the Europe Glucagon-Like Peptide-1 Agonists Market over the forecast period
More research could help clarify the contribution of obesity to disease outcomes
